July 8, 2024
Ritrova Therapeutics Announces U.S. FDA Orphan Drug Designation and Rare Pediatric Disease Designation Granted to RIT-003 for the Treatment of Angelman Syndrome
© 2024 Ritrova Therapeutics, Inc. All rights reserved.
info@ritrovatherapeutics.com